University of Nebraska Medical Center

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred & Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers.

The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies. More about iCaRe2.

A patient talks with a health care provider.

For Patients

Participation in the iCaRe2 is entirely voluntary. There is no charge to the subject and no compensation for participation in the registry. Contact us to sign up.

Two researchers in white coats look at a petri dish

For Researchers

The iCaRe2 is available to researchers interested in estimating cancer risk factors, predicting survivorship, aiding in treatment, or evaluating quality of life.

A glass sculpture in the Fred and Pamela Buffett Cancer Center

For Sponsors

To make the difference, we need your help to evolve iCaRe2 into a comprehensive national resource for standardized cancer data collection, mining and sharing.

Illustration of data in health care.

Available Registries

Learn about the registries currently enrolling participants.